FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380626528> ?p ?o ?g. }

• W4380626528 abstract "Abstract Background and aims Despite therapeutic advances, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) carry poor renal and survival outcomes. Prognostic elements are needed to guide treatment. Several studies explored determinants of AAV outcomes, but predictive factors are not well established. Poor prognosis factors have been lower glomerular filtration rate, lower serum C3, C3 deposition on immunofluorescence (IF), and recently platelet count below 250 × 109/L. Histopathological lesions have also been related to renal outcomes. In this study we aim to correlate serum immune and inflammatory biomarkers with renal histological lesions’ severity. Methods We retrospectively analysed histopathological findings of adults with biopsy-proven AAV renal involvement through Berden's histopathological classification (BHC) classes, Brix's renal risk score (BRS), interstitial fibrosis and tubular atrophy (IFTA) and crescentic glomeruli percentages (%), C3 positive IF and presence of interstitial hemorrhage (IH). Patients’ ANCA titer (ANCAd) measured by ELISA, serum C3 and C-reactive protein (CRP) were documented at diagnosis. ANCA titer was also registered at last follow-up date (ANCAf). Univariate statistical analysis was used to correlate every biomarker with every histologic variable mentioned. C3 and CRP were used as continuous variables and ANCA titers as continuous and categorical variables. As a continuous variable, ANCA titers above laboratorial detection were not considered (i.e. &gt;134). Seronegative AAV were not considered for titer analysis. BRS was considered as continuous variable for its score and as categorical for its risk group. Multivariate analysis was used to identify independent predictors renal biopsy findings. Results We included 46 patients with biopsy-proven AAV kidney involvement from January 2006 to January 2023, 65.2% male (n = 30), median age 66.5 (60.75-74.5), 78.3% (36) MPO, 15.2% (7) PR3 and 6.5% (3) seronegative; and 6.5% (3) had concomitant anti-GBM+ (all MPO). Categorization by ANCAd revealed 7.7% (3) 0-19 UI/mL, 7.7% (3) 20-39, 7.7% (3) 40-59, 20.5% (8) 60-99, 12.8% (5) 100-134 and 43.6% &gt;134. According to BHC, biopsies were: 17.4% (8) global sclerotic, 28.3% (13) mixed, 39.1% (18) crescentic, and 15.2% (7) focal. According to BRS, 2.2% (1) had low risk, 28.3% (13) medium risk and 58.7% (27) high risk of ESKD. 5 biopsies had incomplete information for a score result. Median BRS was 9 – high risk. IF C3 was positive 28.3% (16) biopsies, and IH in 10.9% (5). Median % IFTA was 40% and median %crescentic was 33%. In univariate analysis, ANCAd did not correlate to BHC class both as continuous and categorical variable (p = 0.477 and p = 0.685 respectively), nor to %IFTA (p = 0.935, p = 0.938), nor %crescents (p = 0.975, p = 0.938), nor C3 IF staining (p = 0.690, p = 0.344), nor IH presence (p = 0.773, p = 0.897), nor to BRS risk groups (p = 0.339, p = 0.584). ANCAd titer did not correlate to BRS score value (p = 0.072, r = 0.372), both as continous variables. However, ANCAf did correlate to BRS´s risk groups (p = 0.037), with ANCAf values higher in the high-risk compared to the medium-risk group (p = 0.016). In multivariate analysis including age and gender, ANCAf persists as a predictor of BRS´s risk groups (p&lt;0.001, model p&lt;0.001). C3 levels at diagnosis did not have statistically significant correlation with neither histological finding: BHC class (p = 0.282), BRS score (p = 0.683), % IFTA (p = 0.753), % crescents (p = 0.989), C3 on IF (p = 0.472) and IH (p = 0.773). No significant correlation was seen when considering CRP at diagnosis: BHC class (p = 0.162), BRS (p = 0.276), %IFTA (p = 0.343), %crescents (p = 0.071), C3 on IF (p = 0.657) and IH (p = 0.951). Conclusions ANCA titer at diagnosis, serum C3 and CRP did not correlate with histological severity and chronicity lesions in our population. Nonetheless, larger cohorts, systematization of biopsy findings and studies on newer biomarkers might bring helpful information to expected prognosis and initial therapeutic approaches. A positive correlation between ANCA levels at the last follow-up date and medium and high-risk BRS groups on initial biopsy might be further explored in larger studies." @default.
• W4380626528 created "2023-06-15" @default.
• W4380626528 creator A5007415420 @default.
• W4380626528 creator A5019091090 @default.
• W4380626528 creator A5022285414 @default.
• W4380626528 creator A5023903348 @default.
• W4380626528 creator A5032724338 @default.
• W4380626528 creator A5035048589 @default.
• W4380626528 creator A5044024974 @default.
• W4380626528 creator A5051692740 @default.
• W4380626528 creator A5066008681 @default.
• W4380626528 creator A5073802931 @default.
• W4380626528 creator A5087371734 @default.
• W4380626528 date "2023-06-01" @default.
• W4380626528 modified "2023-09-27" @default.
• W4380626528 title "#4790 SERUM BIOMARKERS AS PREDICTORS OF RENAL DAMAGE IN ANCA-ASSOCIATED VASCULITIDES" @default.
• W4380626528 doi "https://doi.org/10.1093/ndt/gfad063c_4790" @default.
• W4380626528 hasPublicationYear "2023" @default.
• W4380626528 type Work @default.
• W4380626528 citedByCount "0" @default.
• W4380626528 crossrefType "journal-article" @default.
• W4380626528 hasAuthorship W4380626528A5007415420 @default.
• W4380626528 hasAuthorship W4380626528A5019091090 @default.
• W4380626528 hasAuthorship W4380626528A5022285414 @default.
• W4380626528 hasAuthorship W4380626528A5023903348 @default.
• W4380626528 hasAuthorship W4380626528A5032724338 @default.
• W4380626528 hasAuthorship W4380626528A5035048589 @default.
• W4380626528 hasAuthorship W4380626528A5044024974 @default.
• W4380626528 hasAuthorship W4380626528A5051692740 @default.
• W4380626528 hasAuthorship W4380626528A5066008681 @default.
• W4380626528 hasAuthorship W4380626528A5073802931 @default.
• W4380626528 hasAuthorship W4380626528A5087371734 @default.
• W4380626528 hasBestOaLocation W43806265281 @default.
• W4380626528 hasConcept C126322002 @default.
• W4380626528 hasConcept C133397671 @default.
• W4380626528 hasConcept C142724271 @default.
• W4380626528 hasConcept C144301174 @default.
• W4380626528 hasConcept C159641895 @default.
• W4380626528 hasConcept C159654299 @default.
• W4380626528 hasConcept C163764329 @default.
• W4380626528 hasConcept C185592680 @default.
• W4380626528 hasConcept C203014093 @default.
• W4380626528 hasConcept C2775934546 @default.
• W4380626528 hasConcept C2780091579 @default.
• W4380626528 hasConcept C2780306776 @default.
• W4380626528 hasConcept C2781087799 @default.
• W4380626528 hasConcept C2781197716 @default.
• W4380626528 hasConcept C38180746 @default.
• W4380626528 hasConcept C55493867 @default.
• W4380626528 hasConcept C71924100 @default.
• W4380626528 hasConcept C90924648 @default.
• W4380626528 hasConceptScore W4380626528C126322002 @default.
• W4380626528 hasConceptScore W4380626528C133397671 @default.
• W4380626528 hasConceptScore W4380626528C142724271 @default.
• W4380626528 hasConceptScore W4380626528C144301174 @default.
• W4380626528 hasConceptScore W4380626528C159641895 @default.
• W4380626528 hasConceptScore W4380626528C159654299 @default.
• W4380626528 hasConceptScore W4380626528C163764329 @default.
• W4380626528 hasConceptScore W4380626528C185592680 @default.
• W4380626528 hasConceptScore W4380626528C203014093 @default.
• W4380626528 hasConceptScore W4380626528C2775934546 @default.
• W4380626528 hasConceptScore W4380626528C2780091579 @default.
• W4380626528 hasConceptScore W4380626528C2780306776 @default.
• W4380626528 hasConceptScore W4380626528C2781087799 @default.
• W4380626528 hasConceptScore W4380626528C2781197716 @default.
• W4380626528 hasConceptScore W4380626528C38180746 @default.
• W4380626528 hasConceptScore W4380626528C55493867 @default.
• W4380626528 hasConceptScore W4380626528C71924100 @default.
• W4380626528 hasConceptScore W4380626528C90924648 @default.
• W4380626528 hasIssue "Supplement_1" @default.
• W4380626528 hasLocation W43806265281 @default.
• W4380626528 hasOpenAccess W4380626528 @default.
• W4380626528 hasPrimaryLocation W43806265281 @default.
• W4380626528 hasRelatedWork W1692967517 @default.
• W4380626528 hasRelatedWork W2366527240 @default.
• W4380626528 hasRelatedWork W2413269103 @default.
• W4380626528 hasRelatedWork W2803690752 @default.
• W4380626528 hasRelatedWork W2888628091 @default.
• W4380626528 hasRelatedWork W2897112912 @default.
• W4380626528 hasRelatedWork W2902032586 @default.
• W4380626528 hasRelatedWork W3002974972 @default.
• W4380626528 hasRelatedWork W3111140953 @default.
• W4380626528 hasRelatedWork W4385591304 @default.
• W4380626528 hasVolume "38" @default.
• W4380626528 isParatext "false" @default.
• W4380626528 isRetracted "false" @default.
• W4380626528 workType "article" @default.